logo

For the Inventor, By the Inventor

Fayetteville, NY, United States of America

Aldo A Algieri

USPTO Granted Patents = 34

Average Co-Inventor Count = 1.9

ph-index = 8

Forward Citations = 199(Granted Patents)


Location History:

  • Fayetteville, NY (US) (1980 - 1988)
  • Killingworth, CT (US) (1990)

Company Filing History:

goldMedal34 out of 637 
 
Bristol-Myers Company
 patents

Years Active: 1980-1990

Loading Chart...
34 patents (USPTO):Explore Patents
1. 4927968 - Chemical intermediates and process (1990-05-22),
2. 4788184 - Substituted 3-cyclobutene-1,2-diones as anti-ulcer agents (1988-11-29),
3. 4772704 - 2,5-disubstituted-4(3H)-pyrimidones having histamine H.sub.2 -receptor (1988-09-20),
4. 4692531 - Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H.sub.2 (1987-09-08),
5. 4644006 - Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H.sub.2 (1987-02-17),
6. 4607105 - 3-cyclobutene-1,2-dione intermediates (1986-08-19),
7. 4600779 - Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H.sub.2 (1986-07-15),
8. 4595758 - Ethanediimidamide intermediates (1986-06-17),
9. 4588826 - Ethanediimidamide intermediates (1986-05-13),
10. 4578471 - Substituted amino alkyl pyridyl ethanediimidamides (1986-03-25),
11. 4546188 - Substituted 1,2-diaminocyclobutene-3,4-diones (1985-10-08),
12. 4539316 - Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones (1985-09-03),
13. 4528378 - Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H.sub.2 (1985-07-09),
14. 4528377 - Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H.sub.2 (1985-07-09),
15. 4528375 - Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H.sub.2 (1985-07-09),

Title: Innovations and Contributions of Aldo A Algieri in Fayetteville, NY

Introduction

Aldo A Algieri, based in Fayetteville, NY, is a prolific inventor with an impressive portfolio of 34 patents to his name. His work primarily focuses on chemical intermediates and novel compounds that have valuable applications in the medical field, particularly in the development of histamine H₂-antagonists and anti-ulcer agents.

Latest Patents

Among his latest patents, Algieri has developed novel intermediates related to the preparation of certain histamine H₂-antagonists. This patent describes compounds where R¹ can be either hydrogen or lower alkyl and highlights their use in a process that enhances the production of beneficial pharmaceutical agents. Furthermore, he has also contributed to the field with his patent on substituted 3-cyclobutene-1,2-diones as potential anti-ulcer agents. This invention specifies complex chemical formulas that include various substituents essential for the synthesis of histamine H₂-antagonist anti-ulcer agents, demonstrating his innovative approach to solving medical challenges.

Career Highlights

Algieri's career has been anchored in the pharmaceutical industry, where he currently works at Bristol-Myers Squibb Company. His dedication to research and development has led to significant advancements in the understanding and creation of medical compounds that contribute to health improvements worldwide.

Collaborations

Throughout his career, Aldo A Algieri has collaborated with notable individuals in the field, including Ronnie R Crenshaw and Robert F Farney. These partnerships have enriched his research and allowed for a more comprehensive approach to the challenges he addresses in his inventions.

Conclusion

Aldo A Algieri's contributions to the field of chemistry and pharmaceuticals are notable not just for the number of patents but for the real-world applications of his inventions. His work continues to impact the development of crucial medical treatments, solidifying his place as a significant innovator in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…